SHADOW FORMULARY

Serial Number 98241646
Registration 7645877
700

Registration Progress

Application Filed
Oct 26, 2023
Under Examination
Sep 10, 2024
Approved for Publication
Jul 16, 2024
Published for Opposition
Jul 16, 2024
Registered
Jan 7, 2025

Trademark Image

SHADOW FORMULARY

Basic Information

Serial Number
98241646
Registration Number
7645877
Filing Date
October 26, 2023
Registration Date
January 7, 2025
Published for Opposition
July 16, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 7, 2025
Registration
Registered
Classes
035

Rights Holder

PETAURI ADVISORS, LLC

16
Address
901 WOODLAND ST., STE 104
WEWORK C/O PETAURI HEALTH, LLC
NASHVILLE, TN 37206

Ownership History

Formulary Insights, LLC

Original Applicant
16
Indianapolis, IN

Formulary Insights, LLC

Owner at Publication
16
Indianapolis, IN

PETAURI ADVISORS, LLC

New Owner After Publication #1
16
NASHVILLE, TN

PETAURI ADVISORS, LLC

Original Registrant
16
NASHVILLE, TN

Legal Representation

Attorney
Thomas Kern

Application History

34 events
Date Code Type Description Documents
Jan 7, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 7, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 2, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 2, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 2, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 2, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 2, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 16, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 16, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Nov 24, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 23, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Nov 20, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Sep 19, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 19, 2024 IUAF S USE AMENDMENT FILED Loading...
Sep 10, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 16, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 16, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 16, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 16, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 26, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 7, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 7, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 7, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 7, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 7, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
May 14, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 13, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 13, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 10, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 10, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 10, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 8, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 1, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 30, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
market research; market research consultation; market research services; market research and business analyses; business consultation services in the health care and biopharma industry; price evaluation and analysis being price comparisons services and cost price analysis in the biopharma industry; market research and analysis relating to market access and reimbursement in the health care and biopharma industry; market research and market research consultation services relating to prescription pharmaceuticals
First Use Anywhere: 20211200
First Use in Commerce: 20211200

Classification

International Classes
035

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"FORMULARY"